II

Calendar No. 952

106TH CONGRESS

2D SESSION S. 2731

[Report No. 106–505]

To amend title III of the Public Health Service Act to enhance the Nation’s

capacity to address public health threats and emergencies.

IN THE SENATE OF THE UNITED STATES

JUNE 14, 2000

Mr. FRIST (for himself, Mr. KENNEDY, Mr. JEFFORDS, Ms. MIKULSKI, Mr.

CLELAND, Mr. COCHRAN, Mr. LIEBERMAN, Mr. KERRY, and Mr. DURBIN) introduced the following bill; which was read twice and referred to

the Committee on Health, Education, Labor, and Pensions

OCTOBER 18 (legislative day, SEPTEMBER 22), 2000

Reported by Mr. JEFFORDS, with amendments

[Omit the part struck through and insert the part printed in italic]

A BILL

To amend title III of the Public Health Service Act to

enhance the Nation’s capacity to address public health

threats and emergencies.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,
2

•S 2731 RS

1 SECTION 1. SHORT TITLE.

2 This Act may be cited as the ‘‘Public Health Threats

3 and Emergencies Act’’.

4 SEC. 2. AMENDMENTS TO THE PUBLIC HEALTH SERVICE

5 ACT.

6 Part B of title III of the Public Health Service Act

7 (42 U.S.C. 243 et seq.) is amended by striking section

8 319 and inserting the following:

9 ‘‘SEC. 319. PUBLIC HEALTH EMERGENCIES.

10 ‘‘(a) EMERGENCIES.—If the Secretary determines,

11 after consultation with the Director of the Centers for Dis12 ease Control and Prevention and other public health offi13 cials as may be necessary, that—

14 ‘‘(1) a disease or disorder presents a public

15 health emergency; or

16 ‘‘(2) a public health emergency, including sig17 nificant outbreaks of infectious diseases or bioter18 rorist attacks, otherwise exists,

19 the Secretary may take such action as may be appropriate

20 to respond to the public health emergency, including mak21 ing grants and entering into contracts and conducting and

22 supporting investigations into the cause, treatment, or

23 prevention of a disease or disorder as described in para24 graphs (1) and (2).

25 ‘‘(b) PUBLIC HEALTH EMERGENCY FUND.—
3

•S 2731 RS

1 ‘‘(1) IN GENERAL.—There is established in the

2 Treasury a fund to be designated as the ‘Public

3 Health Emergency Fund’ to be made available to

4 the Secretary without fiscal year limitation to carry

5 out subsection (a) only if a public health emergency

6 has been declared by the Secretary under such sub7 section. There is authorized to be appropriated to

8 the Fund such sums as may be necessary.

9 ‘‘(2) REPORT.—Not later than 90 days after

10 the end of each fiscal year, the Secretary shall pre11 pare and submit to the Committee on Health, Edu12 cation, Labor, and Pensions of the Senate and the

13 Committee on Commerce of the House of Represent14 atives a report describing—

15 ‘‘(A) the expenditures made from the Pub16 lic Health Emergency Fund in such fiscal year;

17 and

18 ‘‘(B) each public health emergency for

19 which the expenditures were made and the ac20 tivities undertaken with respect to each emer21 gency which was conducted or supported by ex22 penditures from the Fund.

23 ‘‘(c) SUPPLEMENT NOT SUPPLANT.—Funds appro24 priated under this section shall be used to supplement and
4

•S 2731 RS

1 not supplant other Federal, State, and local public funds

2 provided for activities under this section.

3 ‘‘SEC. 319A. NATIONAL NEEDS TO COMBAT THREATS TO

4 PUBLIC HEALTH.

5 ‘‘(a) CAPACITIES.—

6 ‘‘(1) IN GENERAL.—Not later than 1 year after

7 the date of enactment of this section, the Secretary,

8 and such Administrators, Directors, or Commis9 sioners, as may be appropriate, and in collaboration

10 with State and local health officials, shall establish

11 reasonable capacities that are appropriate for na12 tional, State, and local public health systems and the

13 personnel or work forces of such systems. Such ca14 pacities shall be revised every 10 years, or more fre15 quently as the Secretary determines to be necessary.

16 ‘‘(2) BASIS.—The capacities established under

17 paragraph (1) shall improve, enhance or expand the

18 capacity of national, state and local public health

19 agencies to detect and respond effectively to signifi20 cant public health threats, including major out21 breaks of infectious disease, pathogens resistant to

22 antimicrobial agents and acts of bioterrorism. Such

23 capacities may include the capacity to—
5

•S 2731 RS

1 ‘‘(A) recognize the clinical signs and epide2 miological characteristic of significant outbreaks

3 of infectious disease;

4 ‘‘(B) identify disease-causing pathogens

5 rapidly and accurately;

6 ‘‘(C) develop and implement plans to pro7 vide medical care for persons infected with dis8 ease-causing agents and to provide preventive

9 care as needed for individuals likely to be ex10 posed to disease-causing agents;

11 ‘‘(D) communicate information relevant to

12 significant public health threats rapidly to local,

13 State and national health agencies; or

14 ‘‘(E) develop or implement policies to pre15 vent the spread of infectious disease or anti16 microbial resistance.

17 ‘‘(b) REPORT.—Not later than 1 year after the date

18 of enactment of this section, and every 10 years thereafter,

19 the Secretary shall prepare and submit to the Committee

20 on Health, Education, Labor, and Pensions of the Senate

21 and the Committee on Commerce of the House of Rep22 resentatives a report describing the capacities established

23 pursuant to subsection (a).

24 ‘‘(c) (b) SUPPLEMENT NOT SUPPLANT.—Funds ap25 propriated under this section shall be used to supplement
6

•S 2731 RS

1 and not supplant other Federal, State, and local public

2 funds provided for activities under this section.

3 ‘‘(d) (c) TECHNICAL ASSISTANCE.—The Secretary

4 shall provide technical assistance to the States to assist

5 such States in fulfilling the requirements of this section.

6 ‘‘(e) (d) AUTHORIZATION OF APPROPRIATIONS.—

7 There is are authorized to be appropriated to carry out

8 this section such sums as may be necessary for each of

9 the fiscal years 2001 through 2006.

10 ‘‘SEC. 319B. ASSESSMENT OF PUBLIC HEALTH NEEDS.

11 ‘‘(a) PROGRAM AUTHORIZED.—Not later than 1 year

12 after the date of enactment of this section and every 10

13 years thereafter, the Secretary shall award grants to

14 States to perform, in collaboration with local public health

15 agencies, an evaluation to determine the extent to which

16 the States or local public health agencies can achieve the

17 capacities applicable to State and local public health agen18 cies described in subsection (a) of section 319A. The Sec19 retary shall provide technical assistance to States in addi20 tion to awarding such grants.

21 ‘‘(b) PROCEDURE.—

22 ‘‘(1) IN GENERAL.—A State may contract with

23 an outside entity to perform the evaluation described

24 in subsection (a).
7

•S 2731 RS

1 ‘‘(2) METHODS.—To the extent practicable, the

2 evaluation described in subsection (a) shall be com3 pleted by using commonly accepted methods meth4 ods, to be developed by the Secretary in collaboration

5 with State and local health officials, that facilitate

6 the comparison of evaluations conducted by a State to

7 those conducted by other States receiving funds under

8 this section.

9 ‘‘(c) REPORT BY STATE.—Not later than 1 year after

10 the date on which a State receives a grant under this sub11 section, such State shall prepare and submit to the Sec12 retary a report describing the results of the evaluation de13 scribed in subsection (a) with respect to such State.

14 ‘‘(d) SUPPLEMENT NOT SUPPLANT.—Funds appro15 priated under this section shall be used to supplement and

16 not supplant other Federal, State, and local public funds

17 provided for activities under this section.

18 ‘‘(E) (e) AUTHORIZATION OF APPROPRIATIONS.—

19 There is are authorized to be appropriated to carry out

20 this section such sums as may be necessary for each of

21 the fiscal years 2002 and 2003.

22 ‘‘SEC. 319C. GRANTS TO IMPROVE STATE AND LOCAL PUB23 LIC HEALTH AGENCIES.

24 ‘‘(a) PROGRAM AUTHORIZED.—The Secretary shall

25 award competitive grants to eligible entities to address
8

•S 2731 RS

1 core public health capacity needs using the capacities de2 veloped under section 319A, with a particular focus on

3 building capacity to identify, detect, monitor, and respond

4 to threats to the public health.

5 ‘‘(b) ELIGIBLE ENTITIES.—A State or political sub6 division of a State, or a consortium of 2 or more States

7 or political subdivisions of States, that has completed an

8 evaluation under section 319B(a), or an evaluation that

9 is substantially equivalent as determined by the Secretary

10 under section 319B(a), shall be eligible for grants under

11 subsection (b) (a).

12 ‘‘(c) USE OF FUNDS.—An eligible entity that receives

13 a grant under subsection (b) (a), may use funds received

14 under such grant to—

15 ‘‘(1) train public health personnel;

16 ‘‘(2) develop, enhance, coordinate, or improve

17 participation in an electronic network by which dis18 ease detection and public health related information

19 can be rapidly shared among national, regional,

20 State, and local public health agencies and health

21 care providers;

22 ‘‘(3) develop a plan for responding to public

23 health emergencies, including significant outbreaks

24 of infectious diseases or bioterrorism attacks, which

25 is coordinated with the capacities of applicable na-
9

•S 2731 RS

1 tional, State, and local national local, and national

2 health agencies; and

3 ‘‘(4) enhance laboratory capacity and facilities.

4 ‘‘(d) REPORT.—Not later than 1 year after the date

5 of enactment of this section and annually thereafter, the

6 Secretary shall prepare and submit to the Committee on

7 Health, Education, Labor, and Pensions of the Senate and

8 the Committee on Commerce of the House of Representa9 tives a report that describes the activities carried out

10 under this section.

11 ‘‘(d) REPORT.—No later than January 1, 2005, the

12 Secretary shall prepare and submit to the Committee on

13 Health, Education, Labor, and Pensions of the Senate and

14 the Committee on Commerce of the House of Representatives

15 a report that describes the activities carried out under sec16 tions 319A, 319B, and 319C.

17 ‘‘(e) SUPPLEMENT NOT SUPPLANT.—Funds appro18 priated under this section shall be used to supplement and

19 not supplant other Federal, State, and local public funds

20 provided for activities under this section.

21 ‘‘(f) AUTHORIZATION OF APPROPRIATIONS.—There

22 is are authorized to be appropriated to carry out this sec23 tion such sums as may be necessary for each of the fiscal

24 years 2001 through 2006.
10

•S 2731 RS

1 ‘‘SEC. 319D. REVITALIZING THE CENTERS FOR DISEASE

2 CONTROL AND PREVENTION.

3 ‘‘(a) FINDINGS.—Congress finds that the Centers for

4 Disease Control and Prevention have an essential role in

5 defending against and combatting public health threats of

6 the twenty-first century and requires secure and modern

7 facilities that are sufficient to enable such Centers to con8 duct this important mission.

9 ‘‘(b) AUTHORIZATION OF APPROPRIATIONS.—For the

10 purposes of achieving the mission of the Centers for Dis11 ease Control and Prevention described in subsection (a),

12 for constructing new facilities and renovating existing fa13 cilities of such Centers, including laboratories, laboratory

14 support buildings, health communication facilities, office

15 buildings and other facilities and infrastructure, for better

16 conducting the capacities described in section 319A, and

17 for supporting related public health activities, there are

18 authorized to be appropriated such sums as may be nec19 essary for each of fiscal years 2001 through 2010.

20 ‘‘SEC. 319E. COMBATING ANTIMICROBIAL RESISTANCE.

21 ‘‘(a) TASK FORCE.—

22 ‘‘(1) IN GENERAL.—The Secretary shall estab23 lish an Antimicrobial Resistance Task Force to co24 ordinate provide advice and recommendations to the

25 Secretary on Federal programs relating to anti26 microbial resistance. The Secretary may appoint or
11

•S 2731 RS

1 select a committee, or other organization in existence

2 as of the date of enactment of this section, to serve

3 as such a task force, if such committee, or other or4 ganization meets the requirements of this section.

5 ‘‘(2) MEMBERS OF TASK FORCE.—The task

6 force described in paragraph (1) shall be composed

7 of representatives from such Federal agencies, public

8 health constituencies, manufacturers, medical profes9 sional societies and others as determined to be nec10 essary by the Secretary, to develop and implement

11 provide advice and recommendations regarding a

12 comprehensive strategic plan to address the public

13 health threat of antimicrobial resistance.

14 ‘‘(3) AGENDA.—

15 ‘‘(A) IN GENERAL.—The task force de16 scribed in paragraph (1) shall consider factors

17 the Secretary considers appropriate,

18 including—

19 ‘‘(i) public health factors contributing

20 to increasing antimicrobial resistance;

21 ‘‘(ii) public health needs to detect and

22 monitor antimicrobial resistance;

23 ‘‘(iii) detection, prevention, and con24 trol strategies for resistant pathogens;
12

•S 2731 RS

1 ‘‘(iv) the need for improved informa2 tion and data collection;

3 ‘‘(v) the assessment of the risk im4 posed by pathogens presenting a threat to

5 the public health; and

6 ‘‘(vi) any other issues which the Sec7 retary determines are relevant to anti8 microbial resistance.

9 ‘‘(B) DETECTION AND CONTROL.—The

10 Secretary, in consultation with the task force

11 described in paragraph (1) and State and local

12 public health officials, shall—

13 ‘‘(i) develop, improve, coordinate or

14 enhance participation in a surveillance plan

15 to detect and monitor emerging anti16 microbial resistance; and

17 ‘‘(ii) develop, improve, coordinate or

18 enhance participation in an integrated in19 formation system to assimilate, analyze,

20 and exchange antimicrobial resistance data

21 between public health departments.

22 ‘‘(4) MEETINGS.—The task force described

23 under paragraph (1) shall convene not less than

24 twice a year, or more frequently as the Secretary de25 termines to be appropriate.
13

•S 2731 RS

1 ‘‘(b) RESEARCH AND DEVELOPMENT OF NEW ANTI2 MICROBIAL DRUGS AND DIAGNOSTICS.—The Director of

3 the National Institute Institutes of Health and the Direc4 tor of the Center Centers for Disease Control and Preven5 tion, in collaboration with members consistent with the rec6 ommendations of the task force established under sub7 section (a), shall conduct and support research, investiga8 tions, experiments, demonstrations, and studies in the

9 health sciences that are related to—

10 ‘‘(1) the development of new therapeutics, in11 cluding vaccines and antimicrobials, against resist12 ant pathogens;

13 ‘‘(2) the development or testing of medical

14 diagnostics to detect pathogens resistant to

15 antimicrobials;

16 ‘‘(3) the epidemiology, mechanisms, and patho17 genesis of antimicrobial resistance;

18 ‘‘(4) the sequencing of the genomes of priority

19 pathogens as determined by the Director of the Na20 tional Institutes of Health in consultation with the

21 task force established under subsection (a); and

22 ‘‘(5) other relevant research areas.

23 ‘‘(c) EDUCATION OF MEDICAL AND PUBLIC HEALTH

24 PERSONNEL.—The Secretary, after consultation with the

25 Surgeon General, the Director of the Centers for Disease
14

•S 2731 RS

1 Control and Prevention, the Director of Administrator of

2 the Health Resources and Services Administration, the Di3 rector of the Agency for Healthcare Research and Quality,

4 members of the task force described in subsection (a), and

5 professional organizations and societies, shall—

6 ‘‘(1) develop and implement educational pro7 grams to increase the awareness of the general pub8 lic with respect to the public health threat of anti9 microbial resistance and the appropriate use of anti10 biotics;

11 ‘‘(2) develop and implement educational pro12 grams to instruct health care professionals in the

13 prudent use of antibiotics; and

14 ‘‘(3) develop and implement programs to train

15 laboratory personnel in the recognition or identifica16 tion of resistance in pathogens.

17 ‘‘(d) GRANTS.—

18 ‘‘(1) IN GENERAL.—The Secretary shall award

19 competitive grants to eligible entities to enable such

20 entities to increase the capacity to detect, monitor,

21 and combat antimicrobial resistance.

22 ‘‘(2) ELIGIBLE ENTITIES.—Eligible entities for

23 grants under paragraph (1) shall be State or local

24 public health agencies.
15

•S 2731 RS

1 ‘‘(3) USE OF FUNDS.—An eligible entity receiv2 ing a grant under paragraph (1) shall use funds

3 from such grant for activities that are consistent

4 with the factors identified by the task force under

5 subsection (a)(3), which may include activities

6 that—

7 ‘‘(A) provide training to enable such entity

8 to identify patterns of resistance rapidly and

9 accurately;

10 ‘‘(B) develop, improve, coordinate or en11 hance participation in information systems by

12 which data on resistant infections can be shared

13 rapidly among relevant national, State, and

14 local health agencies and health care providers;

15 and

16 ‘‘(C) develop and implement policies to

17 control the spread of antimicrobial resistance.

18 ‘‘(e) GRANTS FOR DEMONSTRATION PROGRAMS.—

19 ‘‘(1) IN GENERAL.—The Secretary shall award

20 competitive grants to eligible entities to establish

21 demonstration programs to promote judicious use of

22 antimicrobial drugs or control the spread of anti23 microbial-resistant pathogens.

24 ‘‘(2) ELIGIBLE ENTITIES.—Eligible entities for

25 grants under paragraph (1) may include hospitals,
16

•S 2731 RS

1 clinics, institutions of long-term care, or professional

2 medical societies professional medical societies, or

3 other public or private nonprofit entities.

4 ‘‘(3) TECHNICAL ASSISTANCE.—The Secretary

5 shall provide appropriate technical assistance to eli6 gible entities that receive grants under paragraph

7 (1).

8 ‘‘(f) SUPPLEMENT NOT SUPPLANT.—Funds appro9 priated under this section shall be used to supplement and

10 not supplant other Federal, State, and local public funds

11 provided for activities under this section.

12 ‘‘(g) AUTHORIZATION OF APPROPRIATIONS.—There

13 are authorized to be appropriated to carry out this section,

14 such sums as may be necessary for each of the fiscal years

15 2001 through 2006.

16 ‘‘SEC. 319F. PUBLIC HEALTH COUNTERMEASURES TO A BIO17 TERRORIST ATTACK.

18 ‘‘(a) WORKING GROUP ON PREPAREDNESS FOR ACTS

19 OF BIOTERRORISM.—The Secretary, in coordination with

20 the Secretary of Defense, shall establish a joint inter21 departmental working group on preparedness and readi22 ness for the medical and public health effects of a bioter23 rorist attack on the civilian population. Such joint working

24 group shall—
17

•S 2731 RS

1 ‘‘(1) coordinate research on pathogens likely to

2 be used in a bioterrorist attack on the civilian popu3 lation as well as therapies to treat such pathogens;

4 ‘‘(2) coordinate research and development into

5 equipment to detect pathogens likely to be used in

6 a bioterrorist attack on the civilian population and

7 protect against infection from such pathogens;

8 ‘‘(3) develop shared standards for equipment to

9 detect and to protect against infection from patho10 gens likely to be used in a bioterrorist attack on the

11 civilian population; and

12 ‘‘(4) coordinate the development, maintenance,

13 and procedures for the release of, strategic reserves

14 of vaccines, drugs, and medical supplies which may

15 be needed rapidly after a bioterrorist attack upon

16 the civilian population.

17 ‘‘(b) WORKING GROUP ON THE PUBLIC HEALTH AND

18 MEDICAL CONSEQUENCES OF BIOTERRORISM.—

19 ‘‘(1) IN GENERAL.—The Secretary, in collabo20 ration with the Director of the Federal Emergency

21 Management Agency and the Attorney General, shall

22 establish a joint interdepartmental working group to

23 address the public health and medical consequences

24 of a bioterrorist attack on the civilian population.

25 ‘‘(2) FUNCTIONS.—Such working group shall—
18

•S 2731 RS

1 ‘‘(A) assess the priorities for and enhance

2 the preparedness of public health institutions,

3 providers of medical care, and other emergency

4 service personnel to detect, diagnose, and re5 spond to a bioterrorist attack; and

6 ‘‘(B) in the recognition that medical and

7 public health professionals are likely to provide

8 much of the first response to such an attack,

9 develop, coordinate, enhance, and assure the

10 quality of joint planning and training programs

11 that address the public health and medical con12 sequences of a bioterrorist attack on the civilian

13 population between—

14 ‘‘(i) local firefighters, ambulance per15 sonnel, police and public security officers,

16 or other emergency response personnel;

17 and

18 ‘‘(ii) hospitals, primary care facilities,

19 or and public health agencies.

20 ‘‘(3) WORKING GROUP MEMBERSHIP.—In estab21 lishing such working group, the Secretary shall act

22 through the Director of the Office of Emergency

23 Preparedness and the Director of the Centers for

24 Disease Control and Prevention.
19

•S 2731 RS

1 ‘‘(4) COORDINATION.—The Secretary shall en2 sure coordination and communication between the

3 working groups established in this subsection and

4 subsection (a).

5 ‘‘(c) GRANTS.—

6 ‘‘(1) IN GENERAL.—The Secretary, in coordina7 tion with the working group established under sub8 section (b), shall award grants on a competitive

9 basis to shall, on a competitive basis and following

10 scientific or technical review, award grants to or

11 enter into cooperative agreements with eligible enti12 ties to enable such entities to increase their capacity

13 to detect, diagnose, and respond to acts of bioter14 rorism upon the civilian population.

15 ‘‘(2) ELIGIBILITY.—To be an eligible entity

16 under this subsection, such entity must be a State,

17 political subdivision of a State, a consortium of 2 or

18 more States or political subdivisions of States, or a

19 hospital, clinic, or primary care facility.

20 ‘‘(3) USE OF FUNDS.—An entity that receives

21 a grant under this subsection shall use such funds

22 for activities that are consistent with the priorities

23 identified by the working group under subsection

24 (b), including—
20

•S 2731 RS

1 ‘‘(A) training health care professionals and

2 public health personnel to enhance the ability of

3 such personnel to recognize the symptoms and

4 epidemiological characteristics of exposure to a

5 potential bioweapon;

6 ‘‘(B) addressing rapid and accurate identi7 fication of potential bioweapons;

8 ‘‘(C) coordinating medical care for individ9 uals exposed to bioweapons; and

10 ‘‘(D) facilitating and coordinating rapid

11 communication of data generated from a bioter12 rorist attack between national, State, and local

13 health agencies.

14 ‘‘(4) COORDINATION.—The Secretary, in award15 ing grants under this subsection, shall—

16 ‘‘(A) notify the Director of the Office of

17 Justice Programs, and the Director of the Na18 tional Domestic Preparedness Office annually

19 as to the amount and status of grants awarded

20 under this subsection; and

21 ‘‘(B) coordinate grants awarded under this

22 subsection with grants awarded by the Office of

23 Emergency Preparedness and the Centers for

24 Disease Control and Prevention for the purpose

25 of improving the capacity of health care pro-
21

•S 2731 RS

1 viders and public health agencies to respond to

2 bioterrorist attacks on the civilian population.

3 ‘‘(5) ACTIVITIES.—An entity that receives a

4 grant under this subsection shall, to the greatest ex5 tent practicable, coordinate activities carried out

6 with such funds with the activities of a local Metro7 politan Medical Response System.

8 ‘‘(d) FEDERAL ASSISTANCE.—The Secretary shall

9 ensure that the Department of Health and Human Serv10 ices is able to provide such assistance as may be needed

11 to State and local health agencies to enable such agencies

12 to respond effectively to bioterrorist attacks.

13 ‘‘(e) EDUCATION.—The Secretary, in collaboration

14 with members of the working group described in sub15 section (b), and professional organizations and societies,

16 shall—

17 ‘‘(1) develop and implement educational pro18 grams to instruct public health officials, medical

19 professionals, and other personnel working in health

20 care facilities in the recognition and care of victims

21 of a bioterrorist attack; and

22 ‘‘(2) develop and implement programs to train

23 laboratory personnel in the recognition and identi24 fication of a potential bioweapon.
22

•S 2731 RS

1 ‘‘(f) FUTURE RESOURCE DEVELOPMENT.—The Di2 rector of National Institutes of Health and the Director

3 of the Centers for Disease Control and Prevention shall

4 consult with the working group described in subsection

5 (a), to develop priorities for and conduct research, inves6 tigations, experiments, demonstrations, and studies in the

7 health sciences related to—

8 ‘‘(1) the epidemiology and pathogenesis of po9 tential bioweapons;

10 ‘‘(2) the development of new vaccines or other

11 therapeutics against pathogens likely to be used in

12 a bioterrorist attack;

13 ‘‘(3) the development of medical diagnostics to

14 detect potential bioweapons; and

15 ‘‘(4) other relevant research areas.

16 ‘‘(g) REPORT.—Not later than 180 days after the

17 date of enactment of this section, and annually, on June

18 30 of each year thereafter, the Secretary shall prepare and

19 submit to the Committee on Health, Education, Labor,

20 and Pensions of the Senate, the Committee on Commerce

21 of the House of Representatives, the Committee on Armed

22 Services of the Senate, the Committee on Armed Services

23 of the House of Representatives, and other congressional

24 committees as may be appropriate, a report that—
23

•S 2731 RS

1 ‘‘(1) details the activities carried out by the

2 working groups under subsections (a) and (b) during

3 the fiscal year preceding the date on which the re4 port is submitted and describing such activities to be

5 undertaken by Federal agencies to combat bioter6 rorism in the subsequent year;

7 ‘‘(2) describes the programs carried out under

8 subsection (c); and

9 ‘‘(3) describes activities carried out by the Sec10 retary under subsections (d) and (e).

11 ‘‘(h) (g) GENERAL ACCOUNTING OFFICE REPORT.—

12 Not later than 180 days after the date of enactment of

13 this section, the Comptroller General shall submit to the

14 Committee on Health, Education, Labor, and Pensions of

15 the Senate and the Committee on Commerce of the House

16 of Representatives a report that describes—

17 ‘‘(1) Federal activities primarily related to re18 search on, preparedness for, and the management of

19 the public health and medical consequences of a bio20 terrorist attack against the civilian population;

21 ‘‘(2) the coordination of the activities described

22 in paragraph (1);

23 ‘‘(3) the amount of Federal funds authorized or

24 appropriated for the activities described in para25 graph (1); and
24

•S 2731 RS

1 ‘‘(4) the effectiveness of such efforts in pre2 paring national, State, and local authorities to ad3 dress the public health and medical consequences of

4 a potential bioterrorist attack against the civilian

5 population.

6 ‘‘(i) (h) SUPPLEMENT NOT SUPPLANT.—Funds ap7 propriated under this section shall be used to supplement

8 and not supplant other Federal, State, and local public

9 funds provided for activities under this section.

10 ‘‘(j) (i) AUTHORIZATION OF APPROPRIATIONS.—

11 There is are authorized to be appropriated to carry out

12 this section such sums as may be necessary for each of

13 the fiscal years 2001 through 2006.’’.

Calendar No. 952

106TH CONGRESS

2D SESSION S. 2731

[Report No. 106–505]

A BILL

To amend title III of the Public Health Service Act

to enhance the Nation’s capacity to address public health threats and emergencies.

OCTOBER 18 (legislative day, SEPTEMBER 22), 2000

Reported with amendments